데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다
1138245-13-2CCC1=C[C@@H]2[C@H](C1)C[C@]2(CN)CC(=O)OFTBQORVNHOIASH-CKYFFXLPSA-N1138245-13-2DTXSID001032301CHEMBL3545125안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
N - Nervous system;N02 - Analgesics;N02B - Other analgesics and antipyretics;N02BF - Gabapentinoids;N02BF03 - Mirogabalin
QN - Nervous system;QN02 - Analgesics;QN02B - Other analgesics and antipyretics;QN02BF - Gabapentinoids;QN02BF03 - Mirogabalin
개요Mirogabalin is a calcium channel blocker with analgesic effects. It binds to the α2δ-1 and α2δ-2 subunits of voltage-dependent Ca2+ channels. Mirogabalin has potent and sustained analgesic effects (ED50 = 2.5 mg/kg) in rats with diabetes induced by streptozotocin (STZ; ). Mirogabalin does not inhibit activities associated with CNS adverse effects of analgesics, such as rotarod performance (ID50 = 9.4 mg/kg) or locomotor activity (ID50 = 43.9 mg/kg), at its effective dose. Formulations containing mirogabalin are in clinical trials for diabetic peripheral neuropathic pain.
용도Mirogabalin is a two alpha2delta ligand which is investigated for the treatment of peripheral neuropathic pain, postherpetic neuralgia and fibromyalgia, showing promising results in patients with diabetic peripheral neuropathy.
불러오는 중…